Suppr超能文献

糖尿病与非糖尿病患者大型非心脏手术后的高血糖反应及激素治疗的附加作用。

The hyperglycemic response to major noncardiac surgery and the added effect of steroid administration in patients with and without diabetes.

机构信息

From the Departments of General Anesthesiology, Outcomes Research, Quantitative Health Sciences, and Vascular Surgery, Cleveland Clinic, Cleveland, Ohio.

出版信息

Anesth Analg. 2013 May;116(5):1116-1122. doi: 10.1213/ANE.0b013e318288416d. Epub 2013 Apr 4.

Abstract

BACKGROUND

The pattern and magnitude of the hyperglycemic response to surgical stress, the added effect of low-dose steroids, and whether these differ in diabetics and nondiabetics remain unclear. We therefore tested 2 hypotheses: (1) that diabetics show a greater increase from preoperative to intraoperative glucose concentrations than nondiabetics; and (2) that steroid administration increases intraoperative hyperglycemia more so in diabetics compared with nondiabetics.

METHODS

Patients scheduled for major noncardiac surgery under general anesthesia were enrolled and randomized to preoperative IV 8 mg dexamethasone or placebo, stratified by diagnosis of diabetes. Patients were part of a larger underlying trial (the Dexamethasone, Light Anesthesia and Tight Glucose Control [DeLiT] Trial). IV insulin was given when glucose concentration exceeded 215 mg/dL. The primary outcome measure was the change in glucose from the preoperative to maximal intraoperative glucose concentration. We also report the time-dependent pattern of intraoperative hyperglycemia.

RESULTS

Ninety patients (23% with diabetes) were randomized to dexamethasone, and 95 (29% with diabetes) were given placebo. The mean ± SD change from preoperative to maximal intraoperative glucose concentration was 63 ± 69 mg/dL in diabetics and 72 ± 45 mg/dL in nondiabetics. The mean covariable-adjusted change (95% confidence interval) in nondiabetics was 29 (13, 46) mg/dL more than in diabetics (P < 0.001). For all patients combined, mean glucose increased slightly from preoperative to incision, substantially from incision to surgery midpoint, and then remained high and fairly stable through emergence, with nondiabetic patients showing a greater increase (P < 0.001). For nondiabetics, the mean increase in glucose concentration (97.5% CI) was 29 (9, 49) mg/dL more in patients given dexamethasone than placebo (P = 0.0012). However, there was no dexamethasone effect in diabetics (P = 0.99).

CONCLUSIONS

Treatment of intraoperative hyperglycemia should account for the hyperglycemic surgical stress response trend depending on the stage of surgery as well as the added effects of steroid administration. Denying steroid prophylaxis for postoperative nausea and vomiting for fear of hyperglycemic response should be reconsidered given the limited effect of steroids on intraoperative blood glucose concentrations.

摘要

背景

手术应激引起的高血糖反应模式和程度,以及小剂量类固醇的附加作用,以及这些在糖尿病患者和非糖尿病患者中的差异尚不清楚。因此,我们检验了 2 个假设:(1)糖尿病患者的术前至术中血糖浓度升高幅度大于非糖尿病患者;(2)与非糖尿病患者相比,类固醇给药使糖尿病患者术中高血糖加重。

方法

择期全麻下进行非心脏大手术的患者入选并按诊断糖尿病分层随机分为术前静脉 8 mg 地塞米松或安慰剂组。患者是一个更大的基础试验(地塞米松、浅麻醉和严格血糖控制[DeLiT]试验)的一部分。当血糖浓度超过 215 mg/dL 时给予静脉胰岛素。主要结局测量指标为从术前到最大术中血糖浓度的变化。我们还报告了术中高血糖的时间依赖性模式。

结果

90 例患者(23%患有糖尿病)被随机分为地塞米松组,95 例患者(29%患有糖尿病)给予安慰剂。糖尿病患者从术前到最大术中血糖浓度的平均(±SD)变化为 63 ± 69 mg/dL,非糖尿病患者为 72 ± 45 mg/dL。非糖尿病患者的平均(95%置信区间)调整后变量变化为 29(13,46)mg/dL 大于糖尿病患者(P < 0.001)。所有患者的血糖浓度从术前到切口略有升高,从切口到手术中点明显升高,然后在苏醒过程中保持较高且相当稳定,非糖尿病患者的升高幅度更大(P < 0.001)。对于非糖尿病患者,接受地塞米松治疗的患者血糖浓度升高(97.5%CI)平均为 29(9,49)mg/dL 高于安慰剂组(P = 0.0012)。然而,糖尿病患者中没有地塞米松的作用(P = 0.99)。

结论

术中高血糖的治疗应考虑手术阶段的高血糖手术应激反应趋势,以及类固醇给药的附加作用。由于类固醇对术中血糖浓度的影响有限,对于因担心高血糖反应而拒绝术后恶心呕吐预防性使用类固醇的做法应重新考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验